SOURCE: Kalorama Information

Kalorama Information

April 20, 2009 14:42 ET

Growth in Biopharma Boon for Cell Culture Industry

NEW YORK, NY--(Marketwire - April 20, 2009) - Growth in the biopharmaceutical market, stemming from the demonstrable ability of biologicals to address unmet medical needs, is creating an unprecedented increase in demand for cell culture products, notes leading life science market research publisher Kalorama Information in its new report "Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition."

The world cell culture market, which includes media, sera and reagents utilized in biopharmaceutical research and biomanufacturing, has been expanding at a healthy double-digit rate to reach $2.1 billion in 2008, and sales are expected to continue their climb with annual growth estimated at 13% through 2013.

Growth in biopharmaceutical manufacturing is the most significant driver of the cell culture market. It is estimated there are more than 400 biopharmaceutical products and vaccines currently in clinical trials targeting more than 200 diseases, including various cancers, Alzheimer's disease, heart disease, diabetes, multiple sclerosis, AIDS and arthritis. Biopharmaceutical products are developed from large, complex protein molecules, which require equally complex manufacturing methods using cell cultures and an array of analytical techniques. Since growing cells for biopharmaceutical production is slow, expensive and complicated, optimizing cell culture development is of paramount concern to companies developing biopharmaceuticals.

"As the biopharmaceutical market grows, the cell culture market follows," said Bruce Carlson, publisher for Kalorama Information. "About one in every four drugs launched on the market is a biopharmaceutical, which makes the supply of cell culture media and components essential."

Additional growth in the cell culture market should come from President Barak Obama's reversal of the Bush administration's restrictions on federal funding of human embryonic stem cell research in March 2009. This will propel the development of novel approaches to treating illnesses for which there are currently few if any therapeutic options. The development of culturing protocols and technologies for stem cells will in turn boost the cell culture market.

Kalorama Information's new report, "Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition," discusses the technologies and techniques currently employed and emerging and analyzes the major trends driving growth in the world market for cell cultures. The study provides market size, growth and forecasts, regional breakdowns, and a competitive analysis of leading providers. For further information visit:

About Kalorama Information

Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of custom research services. We routinely assist the media with healthcare topics.

Contact Information